Literature DB >> 22179575

De-ubiquitinating protease USP2a targets RIP1 and TRAF2 to mediate cell death by TNF.

A-L Mahul-Mellier1, E Pazarentzos, C Datler, R Iwasawa, G AbuAli, B Lin, S Grimm.   

Abstract

Components of the TNFR1 complex are subject to dynamic ubiquitination that impacts on their effects as signalling factors. We have found that the ubiquitin-specific protease USP2a has a pivotal role in the decision for cell death or survival by the TNFR1 complex. This enzyme is a novel component of the TNFR1 complex that is recruited upon ligand binding and controls the signalling activity of the TNFR1-interacting protein RIP1 by removing its K63-linked ubiquitin chains. USP2a similarly de-ubiquitinates TRAF2, a ubiquitin-ligase recruited to the TNFR1 complex. During the TNF response the activity of USP2a on RIP1 and TRAF2 is required for the efficient reappearance of IκBα, which is essential to inactivate the anti-apoptotic transcription factor NF-κB. The effects of USP2a culminate in the conversion of the anti-apoptotic TNFR1 complex I into the pro-apoptotic TNFR1 complex II. Consequently, downregulation of USP2a promotes NF-κB activation and protects cells against TNF-induced cell death.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22179575      PMCID: PMC3321630          DOI: 10.1038/cdd.2011.185

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  40 in total

1.  Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes.

Authors:  Olivier Micheau; Jürg Tschopp
Journal:  Cell       Date:  2003-07-25       Impact factor: 41.582

Review 2.  Regulation of death receptor signaling by the ubiquitin system.

Authors:  I E Wertz; V M Dixit
Journal:  Cell Death Differ       Date:  2010-01       Impact factor: 15.828

3.  Modulation by caspases of tumor necrosis factor-stimulated c-Jun N-terminal kinase activation but not nuclear factor-kappaB signaling.

Authors:  Alison F Littlejohn; Steven J Tucker; Ahmed A A Mohamed; Stephen McKay; Matt J Helms; Peter Vandenabeele; David J MacEwan
Journal:  Biochem Pharmacol       Date:  2003-01-01       Impact factor: 5.858

4.  Crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes: affinity, specificity, and regulation.

Authors:  Chao Zheng; Venkataraman Kabaleeswaran; Yaya Wang; Genhong Cheng; Hao Wu
Journal:  Mol Cell       Date:  2010-04-09       Impact factor: 17.970

5.  Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice.

Authors:  E G Lee; D L Boone; S Chai; S L Libby; M Chien; J P Lodolce; A Ma
Journal:  Science       Date:  2000-09-29       Impact factor: 47.728

6.  CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.

Authors:  Eirini Trompouki; Eudoxia Hatzivassiliou; Theodore Tsichritzis; Hannah Farmer; Alan Ashworth; George Mosialos
Journal:  Nature       Date:  2003-08-14       Impact factor: 49.962

7.  TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosis.

Authors:  James E Vince; Delara Pantaki; Rebecca Feltham; Peter D Mace; Stephanie M Cordier; Anna C Schmukle; Angelina J Davidson; Bernard A Callus; Wendy Wei-Lynn Wong; Ian E Gentle; Holly Carter; Erinna F Lee; Henning Walczak; Catherine L Day; David L Vaux; John Silke
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

8.  UBP41 is a proapoptotic ubiquitin-specific protease.

Authors:  Andreas Gewies; Stefan Grimm
Journal:  Cancer Res       Date:  2003-02-01       Impact factor: 12.701

9.  Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2.

Authors:  Sergio E Alvarez; Kuzhuvelil B Harikumar; Nitai C Hait; Jeremy Allegood; Graham M Strub; Eugene Y Kim; Michael Maceyka; Hualiang Jiang; Cheng Luo; Tomasz Kordula; Sheldon Milstien; Sarah Spiegel
Journal:  Nature       Date:  2010-06-24       Impact factor: 49.962

10.  Granzyme B activates procaspase-3 which signals a mitochondrial amplification loop for maximal apoptosis.

Authors:  Sunil S Metkar; Baikun Wang; Michelle L Ebbs; Jin H Kim; Yong J Lee; Srikumar M Raja; Christopher J Froelich
Journal:  J Cell Biol       Date:  2003-03-10       Impact factor: 10.539

View more
  34 in total

1.  USP2a protein deubiquitinates and stabilizes the circadian protein CRY1 in response to inflammatory signals.

Authors:  Xin Tong; Katie Buelow; Anirvan Guha; Rebecca Rausch; Lei Yin
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer.

Authors:  Collin M Blakely; Evangelos Pazarentzos; Victor Olivas; Saurabh Asthana; Jenny Jiacheng Yan; Irena Tan; Gorjan Hrustanovic; Elton Chan; Luping Lin; Dana S Neel; William Newton; Kathryn L Bobb; Timothy R Fouts; Jeffrey Meshulam; Matthew A Gubens; David M Jablons; Jeffrey R Johnson; Sourav Bandyopadhyay; Nevan J Krogan; Trever G Bivona
Journal:  Cell Rep       Date:  2015-04-02       Impact factor: 9.423

Review 3.  Diverse ubiquitin linkages regulate RIP kinases-mediated inflammatory and cell death signaling.

Authors:  Axel Witt; Domagoj Vucic
Journal:  Cell Death Differ       Date:  2017-05-05       Impact factor: 15.828

4.  HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP.

Authors:  Seemana Bhattacharya; Mrinal K Ghosh
Journal:  Cell Oncol (Dordr)       Date:  2015-04-30       Impact factor: 6.730

Review 5.  Striking a balance: autophagy, apoptosis, and necrosis in a normal and failing heart.

Authors:  Wajihah Mughal; Rimpy Dhingra; Lorrie A Kirshenbaum
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

Review 6.  The ubiquitin system: a critical regulator of innate immunity and pathogen-host interactions.

Authors:  Jie Li; Qi-Yao Chai; Cui Hua Liu
Journal:  Cell Mol Immunol       Date:  2016-08-15       Impact factor: 11.530

7.  Knockdown of miR-182 promotes apoptosis via regulating RIP1 deubiquitination in TNF-α-treated triple-negative breast cancer cells.

Authors:  Like Wo; Dezhao Lu; Xidong Gu
Journal:  Tumour Biol       Date:  2016-07-30

Review 8.  The role of deubiquitinases in breast cancer.

Authors:  Zhenna Xiao; Peijing Zhang; Li Ma
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

9.  USP20 (Ubiquitin-Specific Protease 20) Inhibits TNF (Tumor Necrosis Factor)-Triggered Smooth Muscle Cell Inflammation and Attenuates Atherosclerosis.

Authors:  Pierre-Yves Jean-Charles; Jiao-Hui Wu; Lisheng Zhang; Suneet Kaur; Igor Nepliouev; Jonathan A Stiber; Leigh Brian; Rui Qi; Virginia Wertman; Sudha K Shenoy; Neil J Freedman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

10.  MiR-145 promotes TNF-α-induced apoptosis by facilitating the formation of RIP1-FADDcaspase-8 complex in triple-negative breast cancer.

Authors:  Min Zheng; Zhihao Wu; Anqi Wu; Zhenyu Huang; Na He; Xiaohong Xie
Journal:  Tumour Biol       Date:  2016-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.